Stock Events

Stock Events

Achilles Therapeutics (ACHL) Q1 2023 Earnings

10MayConfirmed

Aug 22

Nov 22

Q4 2022

Q1 2023

-0.61

-0.51

-0.42

-0.32

Details

Expected EPS

-0.4

Actual EPS

-0.44

Surprise EPS

-0.04

Surprise Percent

+10%

Description

Achilles Therapeutics (ACHL) has reported earnings of -0.44 per share for Q1 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.